Tecentriq
Tecentriq ingredients
| Active ingredient | Strength |
|---|---|
| Atezolizumab | 1200 mg/20mL, 840 mg/14mL |
What Tecentriq is used for
The FDA lists the approved uses on the official label (below). In the EU, atezolizumab is approved as Tecentriq for:
Urothelial carcinoma Tecentriq as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma (UC): after prior platinum containing chemotherapy, or who are considered cisplatin ineligible, and whose tumours have a PD-L1 expression ≥ 5% (see section 5.1). Early-stage non-small cell lung cancer (NSCLC) Tecentriq as monotherapy is indicated as adjuvant treatment following complete resection and platinum-based chemotherapy for adult patients with NSCLC with a high risk of recurrence whose tumours have PD-L1 expression on ≥ 50% of tumour cells (TC) and who do not have EGFR mutant or ALK positive NSCLC (see section 5.1 for selection criteria). Advanced NSCLC Tecentriq, in combination with bevacizumab, paclitaxel and carboplatin, is indicated for the first-line treatment of adult patients with metastatic non-squamous non small cell lung…
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Tecentriq
- Generic name
- Atezolizumab
- Made by
- Genentech, Inc.
- Forms
- Injection, Solution
- Given
- Intravenous
- Drug class
- Programmed Death Receptor-1 Blocking Antibody
- FDA approval
- Biologic licence (BLA) BLA761034
- On the US market since
- 2016
Official information
- MedlinePlus drug information (search for Atezolizumab)
In India
- Atezolizumab: 2 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Tecentriq?
Tecentriq (Atezolizumab) is a cancer medicine made by Genentech, Inc., approved by the US FDA.
What are the ingredients of Tecentriq?
Tecentriq contains Atezolizumab (1200 mg/20mL, 840 mg/14mL).
Is Tecentriq approved in Europe?
The same active substance is approved in the EU as Tecentriq.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA